Valsartan And Hydrochlorothiazide
Product Images NDC 68258-6095

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 68258-6095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-6095-xx (Ndc 68258 6095 Xx Novartis)

Label for Valsartan and Hydrochlorothiazide tablets, 160 mg/12.5 mg strength, by Dispensing Solutions, Inc. The label indicates the product is prescription only, provides the NDC 68258-6095-XX, and shows warnings about use during pregnancy and instructions to take one tablet orally once daily as directed by a doctor. The label includes lot, expiration, and barcode information as well.*

FDA Label Image

Ndc 68258-6096-xx (Ndc 68258 6096 Xx Novartis)

DispenseQuick label for Valsartan/HCTZ 160 mg/25 mg tablets, labeled as prescription only. The label includes the National Drug Code (NDC) 68258-6096-XX, product number 6096-X, and states each tablet contains 160 mg valsartan and 25 mg hydrochlorothiazide. Warning messages about pregnancy-related fetal harm and common side effects are present. Manufactured by Novartis Pharmaceuticals Corp. and packaged by Dispensing Solutions, Inc. The label also provides storage instructions and a barcode.*

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Valsartan Hct 1)

A line graph showing the effect of several drugs on baseline systolic blood pressure (SBP) measured in mmHg, plotted against percentage SBP <140 mmHg. The drugs compared include Diovan HCT (320/25 mg), Valsartan (320 mg), Hydrochlorothiazide (25 mg), and placebo. The x-axis represents baseline SBP from 140 to 180 mmHg, and the y-axis represents the percentage with SBP under 140 mmHg from 0 to 100%.*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure &lt;90 Mmhg At Week 8 (Valsartan Hct 2)

A line graph depicting the change in diastolic blood pressure (DBP in mmHg) against baseline DBP for four groups: Diovan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. Each group is represented by distinct markers showing the DBP trend across baseline values from 90 to 110 mmHg.*

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure &lt;130 Mmhg At Week 8 (Valsartan Hct 3)

A line graph comparing the percentage of patients achieving target systolic blood pressure (SBP <140 mmHg) versus baseline SBP (mmHg) for Diovan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo groups. The graph illustrates decreasing trends in achieving target SBP with increasing baseline SBP values for each treatment group.*

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure &lt;80 Mmhg At Week 8 (Valsartan Hct 4)

A line graph comparing the percentage of blood pressure reduction from baseline diastolic blood pressure (DBP) in mmHg. It shows data for Diovan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and a placebo, with DBP values on the x-axis ranging from 90 to 110 and percentage reduction on the y-axis from 0 to 100.*

FDA Label Image

Valsartan Chemical Structure (Valsartan Hct 5)

Chemical structure diagram of the active ingredient in Valsartan and Hydrochlorothiazide, showing the molecular arrangement and bonds characteristic of valsartan.*

FDA Label Image

Hydrochlorothiazide Chemical Structure (Valsartan Hct 6)

Chemical structure diagram showing the molecular arrangement of the active ingredient in the product Valsartan and Hydrochlorothiazide. The diagram includes atoms and bonds typical of a sulfonamide group with chlorine substitution visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.